Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A X Delcayre

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Virology|May 1, 1993
Inhibition of Epstein-Barr virus-mediated capping of CD21/CR2 by alpha interferon (IFN-alpha): immediate antiviral activity of IFN-alpha during the early phase of infectionA X Delcayre, M Lotz, W Lernhardt
European Journal of Immunology|December 1, 1987
gp140, the EBV/C3d receptor (CR2) of human B lymphocytes, is involved in cell-free phosphorylation of p120, a nuclear ribonucleoproteinA X Delcayre, A Fiandino, M Barel, et al.
Biochemical and Biophysical Research Communications|March 31, 1989
Enhancement of Epstein-Barr virus/C3d receptor (EBV/C3dR or CR2) and nuclear p120 ribonucleoprotein phosphorylation by specific EBV/C3dR ligands in subcellular fractions of the human B lymphoma cell line, RajiA X Delcayre, A Fiandino, F Lyamani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1988
Monoclonal and anti-idiotypic anti-EBV/C3d receptor antibodies detect two binding sites, one for EBV and one for C3d on glycoprotein 140, the EBV/C3dR, expressed on human B lymphocytesM Barel, A Fiandino, A X Delcayre, et al.
The EMBO Journal|April 1, 1991
Epstein Barr virus/complement C3d receptor is an interferon alpha receptorA X Delcayre, F Salas, S Mathur, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Virology|May 1, 1993
Inhibition of Epstein-Barr virus-mediated capping of CD21/CR2 by alpha interferon (IFN-alpha): immediate antiviral activity of IFN-alpha during the early phase of infectionA X Delcayre, M Lotz, W Lernhardt
European Journal of Immunology|December 1, 1987
gp140, the EBV/C3d receptor (CR2) of human B lymphocytes, is involved in cell-free phosphorylation of p120, a nuclear ribonucleoproteinA X Delcayre, A Fiandino, M Barel, et al.
Biochemical and Biophysical Research Communications|March 31, 1989
Enhancement of Epstein-Barr virus/C3d receptor (EBV/C3dR or CR2) and nuclear p120 ribonucleoprotein phosphorylation by specific EBV/C3dR ligands in subcellular fractions of the human B lymphoma cell line, RajiA X Delcayre, A Fiandino, F Lyamani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1988
Monoclonal and anti-idiotypic anti-EBV/C3d receptor antibodies detect two binding sites, one for EBV and one for C3d on glycoprotein 140, the EBV/C3dR, expressed on human B lymphocytesM Barel, A Fiandino, A X Delcayre, et al.
The EMBO Journal|April 1, 1991
Epstein Barr virus/complement C3d receptor is an interferon alpha receptorA X Delcayre, F Salas, S Mathur, et al.
Pageof 1